🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study consists of two main parts to explore tacabrutideg recommended dosing...
Status
Recruiting
Location
University of Alabama At Birmingham Hospital
Start Date
2021-09-13
Trial ID
NCT05006716
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of taca...
Status
Recruiting
Location
St Bernards Medical Center
Start Date
2025-04-10
Trial ID
NCT06846671
Treatments Being Tested
The purpose of this study is to determine the absorption, metabolism, and e...
Status
Completed
Location
Fortrea Clinical Research Unit Inc
Start Date
2025-01-24
Trial ID
NCT06776679
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of BGB-...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2025-05-29
Trial ID
NCT06970743
Treatments Being Tested
The purpose of this study is to investigate the effect of coadministration ...
Status
Completed
Location
Fortrea Clinical Research Unit Inc
Start Date
2025-04-03
Trial ID
NCT06906809
Treatments Being Tested
The purpose of this study is to measure the safety, preliminary antitumor a...
Status
Recruiting
Location
Mayo Clinic Phoenix
Start Date
2024-11-27
Trial ID
NCT06634589
Treatments Being Tested
This study aims to explore the recommended phase 2 dose and evaluate the sa...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2022-05-06
Trial ID
NCT05294731
Treatments Being Tested
The purpose of this study is to determine the proportion of participants wh...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-05-16
Trial ID
NCT06849713
Treatments Being Tested
This is an open-label, single-arm, phase II study which will assess the saf...
Status
Not Yet Recruiting
Location
UT MD Anderson
Start Date
2026-09-01
Trial ID
NCT07508995
This study is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
Peking University Third Hospital
Start Date
2025-07-19
Trial ID
NCT07005713